Cohen Cheryl 4
4 · Celldex Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Cohen Cheryl
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-06-16+27,200→ 27,200 totalExercise: $22.48Exp: 2032-06-16→ Common Stock (27,200 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]One third vests on the first, second and third anniversaries of the date of grant.